No participants in a study of the German colonoscopy screening program who had a clear colonoscopy developed colorectal cancer almost twelve years after their exam.
Advanced adenomas were also reduced significantly. Read the rest of this entry »
No participants in a study of the German colonoscopy screening program who had a clear colonoscopy developed colorectal cancer almost twelve years after their exam.
Advanced adenomas were also reduced significantly. Read the rest of this entry »
Patients, care partners, survivors, advocates . . . everyone. It’s Our Time!
Watch a video about the promise of cancer research — and its urgency — from the American Association for Cancer Research (AACR).
One flexible sigmoidoscopy screening between the ages of 55 and 64 reduced both colorectal cancer diagnoses and deaths during a randomized clinical trial in the United Kingdom.
After following 170,000 people for more than 11 years, deaths from colorectal cancer were 43 percent lower among those who had a flexible sigmoidoscopy screening. Diagnosis of colorectal cancer was reduced by 33 percent.
This is the first prospective clinical trial that actually proved that examining the rectum and colon with a scope could reduce colorectal cancer deaths. Read the rest of this entry »
Both Dr. Jeffrey Chou and Dr. Yaguang Xi presented research posters at the American Association for Cancer Research annual meeting in Washington this week.
Dr. Chou is the 2009 Lisa Dubow Research Fellow, and Dr. Xi received the award in 2008.
Dr. Xi’s research found a micro-RNA (miRNA) that made colorectal cancer cells more sensitive to 5-FU and also predicted which cells, and potentially which patients, response best to treatment with 5-FU.
Dr. Chou studied whether treating colorectal cancer cells with decitabine (DAC) could produce cancer-testis antigen in the cells and make them sensitive to immunotherapy. Read the rest of this entry »
If you have completed your colorectal cancer treatment within the past two years, researchers at the University of Texas need your help.
Led by Nynikka Palmer, a doctoral student at the University of Texas School of Public Health, a study will explore the goals and plans colorectal cancer survivors have for their health after their treatment is over.
Learn more about the survey or sign up. Read the rest of this entry »